Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

RNAi-Based Drug Development

Oct 01 2003

• By Mark Ratner

Related Content

IP vs. Know-How: in RNAi, the Battle Is Joined

Feb 01 2003

RNAi Revs Up

Oct 01 2002

Related Companies

Alnylam Pharmaceuticals Inc.

Massachusetts Institute of Technology

Rockefeller University

Nucleonics, Inc.

Opko Health

Sirna Therapeutics

Additional Topics

Strategy Legal Issues BioPharmaceutical

More from Legal & IP

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window